Nachrichten zur Pfizer Aktie

‘Died Suddenly’: The documentary on the adverse effects of the Covid vaccines released

By César Mendez The documentary film “Died Suddenly”, which chronicles the major adverse effects reported in the last two years…

Digestive Health Supplements Global Market Report 2022: Ukraine-Russia War Impact

NEW YORK, Nov. 23, 2022 /PRNewswire/ -- Major players in the digestive health supplements market are Amway Corp, Bayer AG,…

World Clinical Trials Racial Representation Data Study 2022 Featuring Novartis, GSK, Pfizer, Johnson & Johnson, AstraZeneca, F. Hoffmann-La Roche, Eli Lilly, Merck & Co, AbbVie, & Bayer

DUBLIN, Nov. 23, 2022 /PRNewswire/ -- The "Clinical Trials - The Importance of Diversity in Clinical Trials" report has been…

Pfizer Outperform

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Bank Credit Suisse hat Pfizer mit "Outperform" und einem Kursziel von 55 US-Dollar in…

ANALYSE-FLASH: Credit Suisse startet Pfizer mit 'Outperform' - Ziel 55 Dollar

ZÜRICH (dpa-AFX) - Die Schweizer Bank Credit Suisse hat Pfizer mit "Outperform" und einem Kursziel…

California Workers Win $125,000 After Vaccine Discrimination Lawsuit

California Workers Win $125,000 After Vaccine Discrimination Lawsuit Authored…

Japan approves COVID antiviral pill as Pfizer, Merck alternative

Japan approved an antiviral pill from Shionogi & Co. to treat Covid-19 after the company provided new data to show…

BioNTech-Aktie: Winkt hier ein großer Kurstreiber?

Die BioNTech-Aktie (WKN: A2PSR2) hat in den Korrekturmodus geschaltet und am Montag um -4,8% auf 158,41 US$ nachgegeben. Das ist…

Insights on the Narcolepsy Therapeutics Global Market to 2028 - Featuring Jazz Pharmaceuticals, Pfizer, Bioprojet and Takeda Pharmaceutical Among Others

DUBLIN, Nov. 21, 2022 /PRNewswire/ -- The "Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type,…

Pfizer (PFE), BioNTech Provide New Data on BA.4/BA.5 Boosters

Pfizer (PFE) and BioNTechs (BNTX) Omicron BA.4/BA.5-adapted bivalent vaccines show improved immune response against newer Omicron sublineages....…

Pfizer: Ersteinschätzung

Zürich (www.aktiencheck.de) - Rating-Update: Trung Huynh, Analyst der Credit Suisse, nimmt die Coverage für die Aktie von Pfizer Inc. (ISIN: US7170811035,…

2 Reasons to Buy Pfizer and 1 Reason to Sell

The pharmaceutical company is looking for a future beyond COVID-19 therapies....…

New Pfizer-BioNTech Covid Vaccine Is More Effective Than The Original, Study Shows

Pfizer-BioNTechs new bivalent Covid-19 vaccine—which targets the original strain and some Omicron subvariants—provides more protection against the virus and its…

Pfizer says omicron booster is better against new subvariants like BQ.1.1 than old shots

Pfizer said the booster triggered more antibodies against omicron BQ.1.1, BA.4.6, BA.2.75.2 and XBB.1 in adults older than 55 compared…

Pfizer booster spurs immune response to new omicron subtypes

Pfizer said its updated COVID-19 booster may offer some protection against newly emerging omicron mutants even though its not an…

BioNTech: Eine ganze Reihe positiver News - Aktienanalyse

Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von BioNTech SE (ISIN: US09075V1026,…

BioNTech: Neue Daten, nächste Zulassung

Am Freitag haben die Biotech-Schmiede BioNTech und sein amerikanischer Partner Pfizer weitere Daten zum an Omikron angepassten Covid-19-Impfstoff vorgelegt. Darüber…

Pfizer, BioNTech Omicron BA.4/BA.5 bivalent booster shot shows response vs emerging subvariants

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biontech: Omikron-Booster wirksam gegen Variante BQ.1.1

- Der Impfstoff von Biontech und Pfizer für die Omikron-Variante des Coronavirus wirkt auch gegen die Untervariante BQ.1.1....…

Pfizer and BioNTech say bivalent booster increases neutralizing antibodies against new omicron variants

Pfizer Inc. and German partner BioNTech SE said Friday a new analysis of data reviewing the immune response…

UPDATE 1-Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 subvariant

...(Adds background on variant) Nov 18 (Reuters) - Pfizer Inc and its......…

Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 in older adults

...(Reuters) - Pfizer Inc and its German partner BioNTech SE said......…

Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages

NEW YORK and MAINZ, GERMANY, NOVEMBER 18, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced…

AMCP Foundation Interns Delve into Oncology, Evidence Gaps, Medication Adherence in Partnership with AbbVie Inc. and Pfizer Inc.

ALEXANDRIA, Va., Nov. 17, 2022 /PRNewswire/ -- AMCP Foundation congratulates the student pharmacists who recently completed immersive managed care centered…

Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection

Pfizer, BioNTech start trial of next-gen COVID-19 vaccine for broader protection

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection

NEW YORK and MAINZ, GERMANY, NOVEMBER 16, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced…

Two years late: Pfizer and Moderna launch research to determine links between Covid vaccine and myocarditis

After two years of inaction and distributing the vaccines with emergency authorizations that allowed them not to do this type…

Pfizer, Roche, Lilly COVID treatments get draft recommendation from UK NHS advisors

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Top Analyst Reports for Pfizer, Goldman Sachs & General Electric

Todays Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), The Goldman Sachs Group, Inc.…

Pfizer And Moderna To Investigate Their Own Vaccines For Myocarditis Risks

Pfizer And Moderna To Investigate Their Own Vaccines For Myocarditis Risks …

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pfizer Inc. ("Pfizer"…

Global Monoclonal Antibodies Market was Valued at US$ 208.32 Bn in 2022 and is Expected to hit a Revenue of US$ 647 Bn at CAGR of 12% Between Forecast Period of 2022-32 | Future Market Insights, Inc.

Increasing Medical Tourism in Asia Pacific is Spurring Demand for Monoclonal Antibodies. The U.S. expected to account for over 46.2%…

Bridgewest Group inks deal with Pfizer to acquire injectable manufacturing plant in Western Australia

MIAMI and PERTH, Australia, Nov. 11, 2022 /PRNewswire/ -- Global private investment firm, Bridgewest Group, recognized for developing innovative companies…

EU-Behörde: Angepasster Biontech-Impfstoff auch für Kinder ab 5 Jahre

AMSTERDAM (dpa-AFX) - Die Europäische Arzneimittelbehörde EMA hat die Zulassung des an die Omikron-Variante angepassten Corona-Impfstoffes von Biontech/Pfizer auch für…

17th CSHL Double Helix Medal dinner raises $5.8 million

Cold Spring Harbor Laboratorys annual gala honors Pfizer Chairman & CEO Dr. Albert Bourla and 2020 Nobel laureate Dr. Jennifer…

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

Learn more about Organicell Regenerative Medicine, Inc.from this latest report.During the peak of the deadly COVID-19 pandemic, one novel therapeutic…

Pfizer/ BioNTech win EU nod to use Omicron booster in children

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer, BioNTech BA.4/BA.5-adapted booster gets CHMP recommendation for 5-11 year olds in EU

Pfizer Inc. and Germany-based partner BioNTech SE said Thursday that their booster dose of the omicron BA.4/BA.5-adapted bivalent…

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union

NEW YORK and MAINZ, GERMANY, November 10, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced…

dpa-AFX ProFeed